BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laureano RS, Sprooten J, Vanmeerbeerk I, Borras DM, Govaerts J, Naulaerts S, Berneman ZN, Beuselinck B, Bol KF, Borst J, Coosemans A, Datsi A, Fučíková J, Kinget L, Neyns B, Schreibelt G, Smits E, Sorg RV, Spisek R, Thielemans K, Tuyaerts S, De Vleeschouwer S, de Vries IJM, Xiao Y, Garg AD. Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 2022;11:2096363. [DOI: 10.1080/2162402x.2022.2096363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Vanmeerbeek I, Govaerts J, Laureano RS, Sprooten J, Naulaerts S, Borras DM, Laoui D, Mazzone M, Van Ginderachter JA, Garg AD. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. Cells 2022;11:3890. [DOI: 10.3390/cells11233890] [Reference Citation Analysis]
2 Aljabali AA, Bashatwah RM, Obeid MA, Mishra V, Mishra Y, Serrano-aroca Á, Lundstrom K, Tambuwala MM. Current state of, prospects for, and obstacles to mRNA vaccine development. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.103458] [Reference Citation Analysis]
3 Garg AD. Immunology of cell death in cancer and infection. Genes Immun 2022. [PMID: 36171397 DOI: 10.1038/s41435-022-00184-6] [Reference Citation Analysis]
4 Kalkusova K, Smite S, Darras E, Taborska P, Stakheev D, Vannucci L, Bartunkova J, Smrz D. Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors. IJMS 2022;23:11080. [DOI: 10.3390/ijms231911080] [Reference Citation Analysis]
5 Caro AA, Deschoemaeker S, Allonsius L, Coosemans A, Laoui D. Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer. Cancers (Basel) 2022;14:4037. [PMID: 36011029 DOI: 10.3390/cancers14164037] [Reference Citation Analysis]